Inc. (AMZN) Delaying a Larger Kindle Fire? Inc. (NASDAQ:AMZN) is announcing a launch event September 6 for some new Kindle devices – but there is chatter than one of the devices not among this new launch is a 10-inch Kindle Fire, which was expected to be a direct competitor to the iPad by Apple Inc. (NASDAQ:AAPL)., Inc. (NASDAQ:AMZN)

Instead of taking on Apple Inc. (NASDAQ:AAPL) directly, it is expected that Inc. (NASDAQ:AMZN) will pivot and instead offer a smaller device, maybe in the 8-inch level, according to some reports. However, Inc. (NASDAQ:AMZN) has indicated that it will launch a new version of the 7-inch Kindle Fire, which is supposed to be thinner and lighter than the original and would include a camera and a higher-resolution screen. There is also some speculation that broadband options may be more available with the new devices. Right now, Kindle Fire has been strictly a Wi-Fi device, but with expected new features, that may need to be shifted for effective use by users.

“Today, Amazon packages 3G with some of its more expensive e-ink readers for free… But that seems like an impossible model when it comes to devices designed to be media hogs. While not optimal to make consumers pay for 3G or 4G, having the option is a feature consumers might be looking for,” said Tricia Duryee of AllThingsD.

Said Shawn Ingram of GottaBeMobile, the new Kindle Touch from Inc. (NASDAQ:AMZN) is expected to have new features with the same touchscreen to be a more formidable competitor to the Nook Simple Touch from Barnes & Noble Inc. (NYSE:BKS). “The new Kindle Touch will likely have a light-up screen that will make reading in the dark much easier for Kindle owners. [And] since Amazon is out of stock of the Kindle Touch now, we assume the light-up model will be available the same day as the September 6 event. If not, the new model will likely go up for pre-order that day with a shipping date sometime shortly after,” Ingram said.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!